Medical Devices · Letter issue date: Oct 2, 2026

Chirp Innovations, LLC

1 extracted findings

FDA source excerpt, selected passage

Failure to establish and maintain a quality system that is appropriate for the specific medical devices designed and manufactured as required by 21 CFR 820.5.

Findings and supporting evidence

Model-assisted readings, not an exhaustive interpretation. Compare with the extracted source findings below.

Findings extracted from the letter

Selected FDA passages, not the complete letter.

Failure to establish and maintain a quality system that is appropriate for the specific medical devices designed and manufactured as required by 21 CFR 820.5.

Sections and clauses cited

As cited in this historical letter, not a statement of current regulatory requirements.

21 CFR 82021 CFR 820.5 21 CFR 820.20 21 CFR 820.22 21 CFR 820.30 21 CFR 820.50 21 CFR 820.100 21 CFR 820.198 21 CFR 807.81(a)(3)(ii)21 CFR 807.81(b)21 CFR 803.1721 CFR 803

For background, see Premarket notification (510(k)). Explore Botable’s work in Medical devices and Quality and regulatory operations.

Keep exploring

For regulated teams

Put this kind of reading to
work on your own records.

Botable builds and runs a custom AI layer around the software you already use, so your team can do the job you hired them for.

Book a call ↗Read the case studies

Chirp Innovations, LLC

Findings and supporting evidence

Findings extracted from the letter

Sections and clauses cited

More medical-device letters

Keep exploring

Put this kind of reading to
work on your own records.

FDA Warning Letter Alerts

Findings and supporting evidence

Findings extracted from the letter

Sections and clauses cited

More medical-device letters

Keep exploring

Put this kind of reading towork on your own records.

Put this kind of reading to
work on your own records.